dehydrotumulosic acid
inhibits phospholipase A2; isolated from Poria cocos; structure in first source
Also Known As:
dehydrotumulosic acid, (3alpha,16alpha)-isomer
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Cao, Cheng:
1 article
(06/2018)
|
| 2. | Duan, Jin-Ao:
1 article
(06/2018)
|
| 3. | Gao, Ting:
1 article
(06/2018)
|
| 4. | Huang, Renjie:
1 article
(06/2018)
|
| 5. | Liu Mingzhu Qi, Mengqiu:
1 article
(06/2018)
|
| 6. | Qian, Dawei:
1 article
(06/2018)
|
| 7. | Shi, Yiwei:
1 article
(06/2018)
|
| 8. | Yang, Wen:
1 article
(06/2018)
|
| 9. | Zhu, Yue:
1 article
(06/2018)
|
| 10. | Cerdá-Nicolás, M:
1 article
(04/2000)
|
Related Diseases
| 1. | Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
06/01/2018
- " Results indicated that differences existed between normal and vascular dementia model rats except dehydrotumulosic acid and kaempferide, which might be due to the pathology of vascular dementia and pharmacological effect of the analytes. " 06/01/2018
- " A fast, sensitive, and reliable ultra-high performance liquid chromatography coupled with tandem mass spectrometry method has been developed and validated for simultaneous quantification of geniposide, polygalaxanthone III, 3,6'-disinapoyl sucrose, α-asarone, β-asarone, poricoic acid A, poricoic acid B, dehydrotumulosic acid, deoxyschizandrin, schizandrin B, and kaempferide in plasma after oral administration of extracts of Jia-Wei-Kai-Xin-San in normal and vascular dementia rats. "
|
| 2. | Edema (Dropsy)
|
|
Related Drugs and Biologics
Related Therapies and Procedures